Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paulo C Rodriguez

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Iscience|November 29, 2023
Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancerNada H Eisa, Vincent M Crowley, Asif Elahi, et al.
Cell Reports|March 5, 2026
Potentiating dendritic cell immunotherapy by interrupting the Semaphorin 4D-induced immune-suppressive barrierSaurabh K Garg, Colin Snyder, Ganesan Ramamoorthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal MetastasesInna Smalley, Zhihua Chen, Manali Phadke, et al.
Nature Communications|August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
The Journal of Clinical Investigation|December 3, 2020
Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in miceCarly M Harro, Jairo Perez-Sanz, Tara Lee Costich, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.
Nature Communications|November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Iscience|November 29, 2023
Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancerNada H Eisa, Vincent M Crowley, Asif Elahi, et al.
Cell Reports|March 5, 2026
Potentiating dendritic cell immunotherapy by interrupting the Semaphorin 4D-induced immune-suppressive barrierSaurabh K Garg, Colin Snyder, Ganesan Ramamoorthi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal MetastasesInna Smalley, Zhihua Chen, Manali Phadke, et al.
Nature Communications|August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
The Journal of Clinical Investigation|December 3, 2020
Methyltransferase inhibitors restore SATB1 protective activity against cutaneous T cell lymphoma in miceCarly M Harro, Jairo Perez-Sanz, Tara Lee Costich, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for ImmunotherapyJiannong Li, Inna Smalley, Zhihua Chen, et al.
Nature Communications|November 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitorsXuefeng Wang, Tingyi Li, Islam Eljilany, et al.
Pageof 12